Skip to content
primarysourced Photonics sector POET
POET
~2 min read · 551 words ·updated 2026-04-29 · confidence 50%

01 — Company

Section role

This section answers who is POET Technologies, how did it get here, and who runs it. POET sits in a different corporate-form bucket than the other two companies on this site — it is an Ontario-incorporated foreign private issuer that files annually on Form 20-F under IFRS rather than 10-K under US-GAAP. Read this section first so that downstream technology, financial, and thesis claims sit on top of a verified corporate spine.

Confidence legend: ✓ verified-primary (SEC filing or POET press release) · ◐ partial / aggregator · ⚠ inferred / estimate.

What’s here

  • Company timeline and milestones — Chronological event log from the 1972 Tandem Resources predecessor entity, through the 2013 rebrand to POET Technologies, the 2016 DenseLight acquisition, the 2020 Sanan joint-venture formation, the 2022-03-14 Nasdaq uplist, the 2024 TSXV delisting, and the December-2025 SPX wholly-owned conversion.
  • Leadership team — CEO Suresh Venkatesan, CFO Tom Mika, President & GM Vivek Rajgarhia, Chief Revenue Officer Raju Kankipati, SVP Global Manufacturing Ghazi Chaoui, plus the engineering and IP bench. Sourced from the 2026-03-31 Form 20-F.
  • M&A history — A small but consequential deal log: DenseLight (2016 in / 2019 out), BB Photonics (2016), the 2024 SPX minority-interest acquisition, and the 2025-12-31 SPX consolidation. POET is more accurately a divestiture-and-recap story than an acquirer.
  • Joint venture history — Dedicated retrospective on POET-Sanan / Super Photonics Xiamen Co., Ltd. (SPX). Formation 2020-10-22, registration 2021-03-12, equity method 2021–2024, two-stage POET buy-in (24.8% on 2024-12-31 + remainder on 2025-12-31), now a wholly-owned PRC subsidiary.
  • Board governance — Six-director board (five independent), four committees (Audit, Compensation, Corporate Governance & Nominating, Ad Hoc Strategy), Lead Independent Director Jean-Louis Malinge, recent committee-chair changes after the June 2025 director-resignation cluster.

Reading order

  • First-time reader / new analyst onboarding: timeline → JV history → leadership → governance. The first two establish the strategic arc and explain why SPX dominates the China-exposure narrative; the latter two show who is executing today.
  • Capital-structure stress test: timeline capital-raise rows → overview. Every raise is dated and sized to a 6-K or 424B5 accession.
  • Governance / proxy season: governance → leadership compensation tables. POET’s foreign-private-issuer status means there is no DEF 14A; governance disclosures live in the 20-F Item 6 and the management information circular published with each annual general meeting.

Discipline reminder

Every fact in this section must cite a primary source — POET’s most recent Form 20-F (accession 0001493152-26-014253, filed 2026-03-31), a 6-K, or a press release on poet-technologies.com. POET’s FPI status creates two research traps: (1) Form 4 filings do not apply (Canadian SEDI / Schedule 13G / Form 144 are the equivalents), and (2) interim results arrive via 6-K, not 10-Q. When a Q&A entry surfaces a new primary-source fact, append it here in the same edit.

Cross-section pointers

  • overview — paired technology view of the Optical Interposer platform whose corporate scaffolding is mapped in timeline.
  • overview — customer / foundry / competitor map; Sanan and SPX appear in both this section and the ecosystem section.
  • overview — capital structure feeds every capital-raise event in timeline.
  • overview — bull / bear / risks pull governance and JV-history items directly from this section.
  • overview — primary source registry; every claim above resolves there.